ArticleInternational journal of hematology2020

Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients.

Yoshimichi Koutake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.